# Apitoria Pharma Private Limited, Pashamylaram, India – FDA Inspections

Source: https://www.keypedia.com/companies/apitoria-pharma-private-limited/66a8b707-c1e8-4661-8b6c-05923855654c

> Inspection records and compliance data for Apitoria Pharma Private Limited in Pashamylaram. 9 FDA inspections on record, 3 Form 483s, last inspected December 12, 2025.

---

## Details

- Name: Apitoria Pharma Private Limited
- FEI Number: 3004051616
- Facility Type: Sterile & Non-Sterile Bulk Drug Manufacturer
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING
- Address Line 1: 73 - 91 95 96 260 261 Plot No 68 - 70, Unit - V; I D A
- City: Pashamylaram
- Country Name: India
- Address: 73 - 91 95 96 260 261 Plot No 68 - 70, Unit - V; I D A, Pashamylaram, India
- Country: India

## Related Documents

- [FDA Inspection 1297984 - Apitoria Pharma Private Limited - 2025-12-12](https://www.keypedia.com/records/fda_inspections/apitoria-pharma-private-limited/62379a54-0c41-43fe-8a5b-520934b4366e) — source: FDA, date: December 12, 2025
- FDA Inspection 1297984 - Apitoria Pharma Private Limited - 2025-12-12 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 12, 2025
- [483 - Apitoria Pharma Private Limited - 2025-12-01](https://www.keypedia.com/records/483/apitoria-pharma-private-limited/6f5e5d42-b274-40c8-a6ea-1599f903fa48) — source: FDA, date: December 1, 2025
- [483 - Apitoria Pharma Private Limited - 2024-12-17](https://www.keypedia.com/records/483/apitoria-pharma-private-limited/d3d1e57d-fbf0-4284-8804-4a4b14ac22c8) — source: FDA, date: December 17, 2024
- [FDA Inspection 1257318 - Apitoria Pharma Private Limited - 2024-12-17](https://www.keypedia.com/records/fda_inspections/apitoria-pharma-private-limited/ed57d611-168b-4050-b11e-5104057cfd1b) — source: FDA, date: December 17, 2024
- FDA Inspection 1257318 - Apitoria Pharma Private Limited - 2024-12-17 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 17, 2024
- FDA Inspection 1245719 - Apitoria Pharma Private Limited - 2023-03-03 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 3, 2023
- [483 - Apitoria Pharma Private Limited - 2022-02-15](https://www.keypedia.com/records/483/apitoria-pharma-private-limited/a2a96815-dbc8-49f1-8248-8b8f140262e7) — source: FDA, date: February 15, 2022
- [483 - Apitoria Pharma Private Limited - 2019-10-28](https://www.keypedia.com/records/483/apitoria-pharma-private-limited/256c0014-cf42-4df3-a59e-37e9d4777227) — source: FDA, date: October 28, 2019
- FDA Inspection 1109465 - Apitoria Pharma Private Limited - 2019-10-28 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 28, 2019
- [483 - Apitoria Pharma Private Limited - 2019-10-21](https://www.keypedia.com/records/483/apitoria-pharma-private-limited/a52b4d24-cefc-44d5-bec4-2c12789effd3) — source: FDA, date: October 21, 2019
- FDA Inspection 1067776 - Apitoria Pharma Private Limited - 2018-07-13 — classification: No Action Indicated (NAI), source: FDA, date: July 13, 2018
- [FDA Inspection 996399 - Apitoria Pharma Private Limited - 2016-10-14](https://www.keypedia.com/records/fda_inspections/apitoria-pharma-private-limited/db5a1173-0ed5-4ae2-8f96-5c24cdb16431) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 14, 2016
- FDA Inspection 996399 - Apitoria Pharma Private Limited - 2016-10-14 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 14, 2016
- FDA Inspection 857097 - Apitoria Pharma Private Limited - 2013-10-11 — classification: No Action Indicated (NAI), source: FDA, date: October 11, 2013

## Related Companies

- [Zydus Lifesciences Limited](https://www.keypedia.com/companies/zydus-lifesciences-limited/4c885aaa-7cca-44f3-a475-13a83042c513)
- [Curia Global, Inc.](https://www.keypedia.com/companies/curia-global-inc/70463a22-7e8e-48fc-9c8d-f781da625c4c)
- [Lonza AG](https://www.keypedia.com/companies/lonza-ag/7084f7e6-ce36-429f-942a-28e759416e70)
- [PCAS Finland Oy](https://www.keypedia.com/companies/pcas-finland-oy/19918537-642f-4d1a-a55b-d8c267e069df)
- [Solara Active Pharma Sciences Limited](https://www.keypedia.com/companies/solara-active-pharma-sciences-limited/acf65b82-5b4f-4ec5-b3c0-56f3eaed2657)
- [Cambrex Profarmaco Milano Srl](https://www.keypedia.com/companies/cambrex-profarmaco-milano-srl/5855fd12-020f-4975-9bc0-f5358c581aef)
- [BrightGene Fine Chemical Co., Ltd (Tongyuan Road)](https://www.keypedia.com/companies/brightgene-fine-chemical-co-ltd-tongyuan-road/6829d08d-3634-4dd8-9018-1479d16cb615)
- [Tianish Laboratories Private Limited](https://www.keypedia.com/companies/tianish-laboratories-private-limited/e097960f-98b1-47f2-877c-d588005879b6)
- [Avantor Inc.](https://www.keypedia.com/companies/avantor-inc/d47a07ba-3a58-4e37-84ec-dd93b3d815db)
- [SAFC, Inc.](https://www.keypedia.com/companies/safc-inc/8b9b439f-c427-4b43-85d2-81ce982736be)

## Related Officers

- [Investigator](https://www.keypedia.com/people/michael-a-charles/f83241f0-ae3b-4535-ac03-e790bbf666ca)
- [Investigator](https://www.keypedia.com/people/kellia-n-hicks/44104c4a-70c1-47fc-9a77-c09c41bacc2b)